Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Lennard

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biochemical and Biophysical Research Communications|January 1, 2003
Identification of residues which regulate activity of the STE20-related kinase hMINKJaeseung Lim, Andrew Lennard, Paul W Sheppard, et al.
AAPS Open|May 16, 2023
Structured content and data management-enhancing acceleration in drug development through efficiency in data exchangeJill Beierle, Marquerita Algorri, Marisol Cortés, et al.
BMC Cell Biology|March 2, 2006
Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signalsGrahame McKenzie, George Ward, Yvette Stallwood, et al.
Journal of Pharmaceutical Sciences|September 29, 2024
Stability modeling methodologies to enable earlier patient accessAndrew Lennard, Boris Zimmermann, Didier Clenet, et al.
PDA Journal of Pharmaceutical Science and Technology|April 20, 2016
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology-Derived Injectable Drug ProductsSerge Mathonet, Hanns-Christian Mahler, Stefan T Esswein, et al.
Clinical Therapeutics|September 13, 2023
Dynamic Regulatory Assessment: Unpacking the Process Reveals Readiness to Pilot for Europe-An EFPIA ViewIain Todd, Ruediger Faust, Esteban Herrero-Martinez, et al.
Journal of Pharmaceutical Sciences|October 5, 2021
The Future of CMC Regulatory Submissions: Streamlining Activities Using Structured Content and Data ManagementKabir Ahluwalia, Michael J Abernathy, Jill Beierle, et al.
The AAPS Journal|July 14, 2021
Meeting Report: N-Nitrosamine Impurity Control Strategies in the Pharmaceutical and Biotechnology IndustriesScott W Roberts, Andrew Lennard, Ganapathy Mohan, et al.
The AAPS Journal|September 28, 2022
Chemistry Manufacturing and Controls Development, Industry Reflections on Manufacture, and Supply of Pandemic Therapies and VaccinesMatthew E Popkin, Markus Goese, Diane Wilkinson, et al.
The AAPS Journal|March 15, 2024
Science- and Risk-Based Stability Strategies to Support Product Lifecycle ChangesLori McCaig, Steven Nowak, Alexander Abbott, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|January 1, 2003
Identification of residues which regulate activity of the STE20-related kinase hMINKJaeseung Lim, Andrew Lennard, Paul W Sheppard, et al.
AAPS Open|May 16, 2023
Structured content and data management-enhancing acceleration in drug development through efficiency in data exchangeJill Beierle, Marquerita Algorri, Marisol Cortés, et al.
BMC Cell Biology|March 2, 2006
Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signalsGrahame McKenzie, George Ward, Yvette Stallwood, et al.
Journal of Pharmaceutical Sciences|September 29, 2024
Stability modeling methodologies to enable earlier patient accessAndrew Lennard, Boris Zimmermann, Didier Clenet, et al.
PDA Journal of Pharmaceutical Science and Technology|April 20, 2016
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology-Derived Injectable Drug ProductsSerge Mathonet, Hanns-Christian Mahler, Stefan T Esswein, et al.
Clinical Therapeutics|September 13, 2023
Dynamic Regulatory Assessment: Unpacking the Process Reveals Readiness to Pilot for Europe-An EFPIA ViewIain Todd, Ruediger Faust, Esteban Herrero-Martinez, et al.
Journal of Pharmaceutical Sciences|October 5, 2021
The Future of CMC Regulatory Submissions: Streamlining Activities Using Structured Content and Data ManagementKabir Ahluwalia, Michael J Abernathy, Jill Beierle, et al.
The AAPS Journal|July 14, 2021
Meeting Report: N-Nitrosamine Impurity Control Strategies in the Pharmaceutical and Biotechnology IndustriesScott W Roberts, Andrew Lennard, Ganapathy Mohan, et al.
The AAPS Journal|September 28, 2022
Chemistry Manufacturing and Controls Development, Industry Reflections on Manufacture, and Supply of Pandemic Therapies and VaccinesMatthew E Popkin, Markus Goese, Diane Wilkinson, et al.
The AAPS Journal|March 15, 2024
Science- and Risk-Based Stability Strategies to Support Product Lifecycle ChangesLori McCaig, Steven Nowak, Alexander Abbott, et al.
Pageof 2